Cancer Research Institute, Tomsk National Research Medical Centre

The Cancer Research Institute is one of the institutes of the Tomsk National Research Medical Centre of the Russian Academy of Sciences, combining a clinic, a reference centre and laboratories in Tomsk in western Siberia; its site lists a cervical cancer vaccination service, a reference centre, a scientific council and its own journal. Counting interventional cancer studies on ClinicalTrials.gov with at least one site in the Russian Federation and a start date from 2023 onwards, it is the most frequent lead sponsor of any organisation, Russian or foreign, ahead of the Blokhin centre and Biocad.